Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Luis J. Marfil-Rivera"'
Autor:
Luz Tarín-Arzaga, Carlos de la Cruz-de la Cruz, Martha A. Reyes-López, Omar Cantu-Martinez, Karina Vázquez-Hernández, Odra Martínez-González, Luis A. González-Torres, Luis J. Marfil-Rivera, David Gómez-Almaguer
Publikováno v:
Medicina Universitaria, Vol 23, Iss 1 (2021)
Lupus anticoagulant (LA) is a heterogeneous group of antibodies that interfere with phospholipid-dependent coagulation tests, which result in abnormally prolonged clotting times in vitro. The prevalence of LA in a healthy individual is 1-5%1,2.
Externí odkaz:
https://doaj.org/article/9d4a03b97ebb4a9da4202e6a3f9048a9
Autor:
Gerald A Soff, Isabelle Ray-Coquard, Luis J Marfil Rivera, Jon Fryzek, Megan Mullins, Lauren C Bylsma, Joseph K Park
Publikováno v:
PLoS ONE, Vol 17, Iss 6, p e0257673 (2022)
BackgroundCurrently, there are no approved options to prevent or treat chemotherapy-induced thrombocytopenia (CIT). We performed a systematic literature review and meta-analysis on use of thrombopoietic agents for CIT.Patients and methodsWe searched
Externí odkaz:
https://doaj.org/article/bd49d84b99e94a02bd85b6d4a280db95
Autor:
Olivia A, Robles-Rodriguez, Jose J, Pe Rez-Trujillo, Arnulfo, Villanueva-Olivo, Laura, Villarreal-Martinez, Luis J, Marfil-Rivera, Humberto, Rodriguez-Rocha, Aracely, Garcia-Garcia, Odila, Saucedo-Cardenas, Maria J, Loera-Arias, Roberto Montes DE, Oca-Luna
Publikováno v:
Journal of biosciences. 45
Hemophilia is a hereditary disorder that can be life-threatening in individuals who have severe spontaneous bleeding resulting from minor trauma or surgery. Although replacement therapy of the missing exogenous factor has improved patients' quality o
Autor:
Luis J. Marfil-Rivera
Publikováno v:
Revista Medicina Universitaria. 21